PWPS
ANIP icon

Pinnacle Wealth Planning Services’s ANI Pharmaceuticals ANIP Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.9K Buy
687
+7
+1% +$562 0.01% 1177
2026
Q1 		$52.3K Buy
680
+279
+70% +$21.8K 0.01% 1177
2025
Q4 		$31.7K Buy
+401
New +$34.7K ﹤0.01% 1488
2021
Q1 		– Sell
-129
Closed -$4K – 428
2020
Q4 		$4K Buy
+129
New +$3.69K ﹤0.01% 1708

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's ANIP Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its ANI Pharmaceuticals (ANIP) stake by 1% in Q2 2026, buying an estimated $562 and bringing the position to 687 shares worth $56.9K. The position accounts for 0.01% of the portfolio, ranked #1177.

Pinnacle Wealth Planning Services first reported a position in ANIP in Q4 2020 and has held it in 4 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Pinnacle Wealth Planning Services held 687 shares of ANI Pharmaceuticals worth $56.9K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 7 ANI Pharmaceuticals shares in Q2 2026, an estimated $562.
  • ANI Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1177 holding.
  • Pinnacle Wealth Planning Services first reported a position in ANI Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.